SEM: שווי פעילות לרווח לפני ריבית, מסים ופחת Select Medical Holdings

Is it worth investing in the Select Medical (SEM) ecosystem, which integrates rehabilitation and intensive care? The shift in the EV/EBITDA ratio clearly demonstrates the market valuation of the business inclusive of debt, where the 11.64 indicator determines the parameter status. Strict licensing barriers guarantee the company's stability, while strategic partnerships with hospital networks effectively block competitor expansion.

This multiple compares the total enterprise value, including net debt, to its operating profit before depreciation and amortization, determining the asset payback period regardless of the tax regime. As Select Medical (SEM) prepares for the spin-off of a major asset, the EV/EBITDA valuation metric, which measures debt and operating leverage, allows for tracking the impact of structural changes and joint ventures on the company's investment attractiveness.